Use cautionMedical device recall · FDA · Published October 5, 2026
Luminex Recalls LIAISON PLEX Assay Due to Diagnosis Risk
Luminex recalls LIAISON PLEX Gram-Negative Blood Culture Assay (Cat. No. 20-005-303) because updated instructions may lead to incorrect or delayed diagnosis of bloodstream infections.
Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.
✎ GovInfoNow plain-language explainer
Luminex Corporation is recalling the LIAISON PLEX Gram-Negative Blood Culture Assay, specifically Catalog No. 20-005-303 across all lots. The recall addresses an issue where the Instructions for Use were updated to recommend repeat testing for positive family-level results, a change intended to prevent incorrect or delayed diagnoses of bloodstream infections. Approximately 30,168 test cartridges (2,514 kits) are affected by this nationwide distribution. Read more at govinfonow.com/recall/2255608-luminex-corporation-recalls-liaison-plex-gram-negative-blood-culture-assay.
“Luminex Recalls LIAISON PLEX Assay Due to Diagnosis Risk.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2255608-luminex-corporation-recalls-liaison-plex-gram-negative-blood-culture-assay. Based on FDA recall #Z-0359-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0359-2027%22&limit=1).
The FDA announced on October 5, 2026, that Luminex Corporation is recalling the LIAISON PLEX Gram-Negative Blood Culture Assay because updated instructions may lead to incorrect or delayed diagnosis of bloodstream infections. The recall affects all lots of catalog number 20-005-303.
The hazard involves instructions for use that were updated to include explicit guidance recommending repeat testing whenever a positive family-level only result is obtained. This issue may contribute to incorrect or delayed diagnosis of bloodstream infection.
Context
GovInfoNow's records show Luminex Corporation has 23 other recalls on record since May 8, 2018. Other recent recalls include the Luminex VERIGENE Gram Negative Blood Culture Test Recall (April 16, 2025), the Luminex Verigene Gram Positive Blood Culture Test Recall (June 20, 2024), and the Luminex VERIGENE BC-GP Utility Tray Recall (November 7, 2023). Other recent recalls of similar products include the Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (July 13, 2026), the Meridian Bioscience Revogene C. difficile Test Recall (December 5, 2025), and the Beckman Coulter Emit 2000 Quinidine Assay Recall (July 13, 2026).
How to tell if you have this one
Check if you have the LIAISON PLEX Gram-Negative Blood Culture Assay with Catalog No. 20-005-303. The recall applies to all lots of this specific catalog number, and the UDI-DI is listed as pending. These products were distributed nationwide within the US.
Brand
Luminex
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Review Updated Instructions
Consult the updated Instructions for Use to ensure you follow the explicit guidance on repeat testing when a positive family-level only result is obtained.
Contact Luminex Corporation
Reach out to Luminex Corporation directly for further information or specific instructions regarding this recall, as no other remedy details are provided in the record.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US distribution nationwide. No OUS distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 37 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0359-2027 (October 5, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0359-2027 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.